M Gnant Selected Research

M Gnant Research Topics

Disease

51	Breast Neoplasms (Breast Cancer) 08/2022 - 01/2000
21	Neoplasms (Cancer) 08/2022 - 01/2000
11	Neoplasm Metastasis (Metastasis) 01/2019 - 03/2008
5	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 02/2015
2	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2017 - 04/2004
2	Brain Neoplasms (Brain Tumor) 01/2012 - 01/2012
2	Colonic Neoplasms (Colon Cancer) 10/2007 - 05/2005
2	Hepatocellular Carcinoma (Hepatoma) 12/2001 - 01/2001
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Osteoporosis 01/2022
1	Diarrhea 01/2019
1	Fistula 01/2018
1	Pancreatic Fistula (Pancreatic Fistulas) 01/2018
1	Residual Neoplasm 01/2017
1	Primary Ovarian Insufficiency 08/2015
1	Hyperglycemia 04/2014
1	Pneumonia (Pneumonitis) 04/2014
1	Stomatitis 04/2014
1	Pathologic Complete Response 02/2014
1	Obesity 09/2013
1	Male Breast Neoplasms (Male Breast Cancer) 06/2013
1	Overweight 04/2013
1	Premature Menopause 10/2012
1	Triple Negative Breast Neoplasms 01/2012
1	Lymphatic Metastasis 05/2010
1	Lung Neoplasms (Lung Cancer) 11/2009
1	Multiple Myeloma 11/2009
1	Hypercalcemia (Milk Alkali Syndrome) 11/2009
1	Calcinosis 03/2009
1	Metabolic Bone Diseases (Osteopenia) 03/2008
1	Bone Diseases (Bone Disease) 03/2008

Drug/Important Bio-Agent (IBA)

15	Hormones (Hormone)IBA 08/2022 - 03/2003
7	Estrogen ReceptorsIBA 01/2021 - 06/2001
5	Trastuzumab (Herceptin)FDA Link 01/2019 - 11/2008
5	Zoledronic Acid (Zometa)FDA Link 03/2016 - 03/2008
5	Aromatase InhibitorsIBA 12/2014 - 12/2011
4	Proteins (Proteins, Gene)FDA Link 08/2022 - 06/2001
4	Biological ProductsIBA 10/2021 - 02/2007
4	Tamoxifen FDA LinkGeneric 01/2021 - 04/2013
4	Diphosphonates (Bisphosphonates)IBA 01/2017 - 03/2008
3	ParaffinIBA 08/2022 - 08/2008
3	Anastrozole (Arimidex)FDA LinkGeneric 01/2021 - 08/2013
3	Progesterone Receptors (Progesterone Receptor)IBA 01/2021 - 04/2003
3	Clodronic Acid (Clodronate)IBA 03/2016 - 03/2008
3	AnthracyclinesIBA 08/2015 - 04/2003
3	Docetaxel (Taxotere)FDA Link 02/2014 - 11/2008
3	Fluorouracil (Carac)FDA LinkGeneric 10/2007 - 04/2003
2	Plasminogen Activator Inhibitor 1IBA 08/2022 - 08/2019
2	human ERBB2 proteinIBA 01/2021 - 05/2010
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2019
2	Epidermal Growth Factor (EGF)IBA 01/2019 - 12/2014
2	Gonadotropin-Releasing Hormone (GnRH)FDA Link 08/2015 - 06/2013
2	Paclitaxel (Taxol)FDA LinkGeneric 08/2015 - 01/2000
2	exemestane (Aromasin)FDA Link 12/2014 - 04/2014
2	Everolimus FDA Link 12/2014 - 04/2014
2	Epirubicin (Ellence)FDA LinkGeneric 02/2014 - 10/2010
2	Estrogens (Estrogen)FDA Link 11/2012 - 10/2012
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 08/2022
1	Plasminogen InactivatorsIBA 08/2022
1	Denosumab FDA Link 01/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022
1	CholesterolIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	Formaldehyde (Formol)FDA Link 01/2021
1	ERRalpha Estrogen-Related ReceptorIBA 01/2019
1	neratinibIBA 01/2019
1	Amylases FDA Link 01/2018
1	Fibrin Tissue Adhesive (Fibrin Sealant)IBA 01/2018
1	Goserelin (Zoladex)FDA Link 02/2015
1	TOR Serine-Threonine KinasesIBA 04/2014
1	Pharmaceutical PreparationsIBA 04/2014
1	Capecitabine (Xeloda)FDA Link 02/2014
1	Estradiol (Delestrogen)FDA LinkGeneric 09/2013
1	Aminoglutethimide (Cytadren)FDA Link 04/2013
1	Dihydrotachysterol (AT 10)IBA 03/2013
1	Phenobarbital (Luminal)FDA Link 01/2012
1	Lapatinib (GW572016)FDA Link 01/2012
1	ProteomeIBA 10/2010
1	Complement System Proteins (Complement)IBA 10/2010
1	Thrombospondin 1IBA 08/2010
1	Vascular Endothelial Growth Factor CIBA 05/2010
1	Taxoids (Taxanes)IBA 11/2008
1	taxaneIBA 11/2008
1	Leucovorin (Folinic Acid)FDA Link 10/2007
1	Levamisole (Decaris)FDA Link 05/2005
1	Interferon-alpha (Interferon Alfa)IBA 05/2005
1	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2003
1	Vinblastine (Vinblastine Sulfate)FDA Link 04/2003
1	Methotrexate (Mexate)FDA LinkGeneric 04/2003

Therapy/Procedure

26	Therapeutics 10/2021 - 05/2005
8	Drug Therapy (Chemotherapy) 01/2017 - 01/2000
6	Neoadjuvant Therapy 10/2021 - 01/2000
6	Adjuvant Chemotherapy 01/2019 - 04/2003
2	Aftercare (After-Treatment) 12/2014 - 04/2014
1	Length of Stay 01/2018
1	Pancreaticoduodenectomy 01/2018
1	Segmental Mastectomy (Lumpectomy) 02/2012
1	Oral Administration 03/2008
1	CMF regimen 04/2003